JAC Advance Access originally published online on June 21, 2007
Journal of Antimicrobial Chemotherapy 2007 60(2):445; doi:10.1093/jac/dkm127
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Comment on: Emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit
1 Paediatric Intensive Care Unit, Alder Hey Children's Hospital, Liverpool, UK 2 Department of Anaesthesia and Intensive Care, Gorizia, Italy 3 Intensive Care Unit, University Hospital of Getafe, Getafe, Madrid, Spain 4 Department of Intensive Care, OLVG, Amsterdam, The Netherlands 5 Department of Intensive Care, VU Medical Center, Amsterdam, The Netherlands 6 Department of Medical Microbiology, University of Liverpool, Liverpool, UK 7 Department of Medical Microbiology, University of Liverpool and Department of Clinical Microbiology and Infection Control, Alder Hey Children's Hospital, Liverpool, UK
* Corresponding author. Tel: +44-151-252-5223; Fax: +44-151-252-5460; E-mail: richard.sarginson@rlc.nhs.uk
Keywords: tobramycin resistance , paromomycin , ESBLs
| The first 10% of the full text of this article appears below. |
Sir,
We read with interest the paper by Al Naiemi et al.1 claiming a link between the emergence of aerobic Gram-negative bacilli (AGNB), producing extended-spectrum ß-lactamase (ESBL), and selective decontamination of the digestive tract (SDD). In particular, the parenteral component of SDD, cefotaxime, is
Transparency declarations